Biolog-id
PrivateLast Round
M&A
Mar 6, 2023
Est. Valuation
$312M
Company Overview
Biolog-id operates in Healthcare & Life Sciences and is based in Bernay. Its latest recorded funding round was a VC Round in November 2019.
Biolog-id is a healthcare technology company that develops and markets RFID-based identification and traceability solutions for sensitive health products such as blood components and chemotherapy injectables.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Supply Chain Tracking, Health IoT, Pharma Supply Chain
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolog-id Comparables
Compare Biolog-id with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spacecode | 83% | |
| IntelliGuard | 82% | |
| InVita Healthcare Technologies | 77% |
For institutional investors. Book with your work email.
Biolog-id Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Mar 6, 2023 | ||||
| VC Round | Nov 20, 2019 | ||||
| VC Round | Nov 30, 2016 | ||||
| Series A | Mar 18, 2011 |
For institutional investors. Book with your work email.
Biolog-id Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xerys | Series A, VC Round |
| Altamira Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 6, 2023
Closed M&A round with a post-money valuation of $312M.
- Nov 20, 2019
$33.17M raised, led by Xerys.
For institutional investors. Book with your work email.
Biolog-id Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biolog-id's valuation, stock price, and market status.
Is Biolog-id a public or private company?
Biolog-id is a private company.
What is the current stock price of Biolog-id?
Biolog-id is a private company, so its shares have no public market price. Caplight tracks Biolog-id's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biolog-id worth (valuation)?
Biolog-id's valuation is estimated at $312.0M based on funding round data.
Can I buy Biolog-id stock?
Biolog-id shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biolog-id's last funding round?
Biolog-id's most recent funding round was M&A on March 6, 2023.
Who are the main investors in Biolog-id?
Key investors in Biolog-id include Xerys.
Will Biolog-id IPO soon?
No public IPO plans have been announced for Biolog-id.
How can I track Biolog-id secondary market activity?
Caplight tracks bids, offers, and trades in Biolog-id's shares on secondary markets.